Cargando…

Correction: Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971772/ https://www.ncbi.nlm.nih.gov/pubmed/35361693 http://dx.doi.org/10.1136/rmdopen-2022-002279corr1

Ejemplares similares

Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases
por: Fragoulis, George E, et al.
Publicado: (2022)

COVID-19 breakthrough infections in rheumatic diseases patients after vaccination
por: Alshukairi, Abeer N., et al.
Publicado: (2022)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply
por: Krause, Philip R, et al.
Publicado: (2022)

Breakthrough infections and acceptance of COVID-19 vaccine boosters: A survey analysis
por: Stevens, Christina W., et al.
Publicado: (2023)

Correction to: Risk Factors Associated With Hospitalization and Death in COVID-19 Breakthrough Infections
Publicado: (2022)

Author Correction: Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
por: Grewal, Ramandip, et al.
Publicado: (2023)

Correction to: Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era
por: Schreiber, Stefan, et al.
Publicado: (2022)

Severe breakthrough COVID-19 after SARS-CoV-2 booster vaccination in an MS patient on ocrelizumab
por: van Kempen, Zoé L.E., et al.
Publicado: (2022)

1467. Breakthrough Omicron Infections in Booster Vaccinated Healthcare Workers
por: Lee, Jeongjae, et al.
Publicado: (2022)

Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study
por: Patel, Naomi J., et al.
Publicado: (2023)

Correction: Impact of autoimmune rheumatic diseases on birth outcomes: a population-based study
Publicado: (2019)

Correction: Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia
Publicado: (2023)

Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy
por: Vanni, Kathleen MM, et al.
Publicado: (2022)

Correction: Comprehensive Sieve Analysis of Breakthrough HIV-1 Sequences in the RV144 Vaccine Efficacy Trial
Publicado: (2016)

Correction: Bullous Pilomatrixoma After COVID-19 Vaccination
por: Alvarez-Rubio, Francisco Javier, et al.
Publicado: (2023)

Correction to: Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022
Publicado: (2023)

Correction to: COVID arm that appeared in the contralateral upper extremity after mRNA‑1273 booster inoculation
por: Sanomachi, Tomomi, et al.
Publicado: (2023)

Correction: High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV brasil registry
Publicado: (2021)

Correction to: Outcomes and Care Quality Metrics for Women of Reproductive Age Living With Rheumatic Heart Disease in Uganda
Publicado: (2020)

Correction: Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodies
por: Nandin, Irene Sanjuan, et al.
Publicado: (2017)

Correction: SARS-CoV-2 vaccine breakthrough infection in the older adults: a meta-analysis and systematic review
por: Jing, Xiaohui, et al.
Publicado: (2023)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Immunogenicity, breakthrough infection, and underlying disease flare after SARS-CoV-2 vaccination among individuals with systemic autoimmune rheumatic diseases
por: Paik, Julie J., et al.
Publicado: (2022)

Correction To: Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants
por: Wang, Qian, et al.
Publicado: (2023)

Correction: Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
Publicado: (2022)

Publisher Correction: Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections
por: Fan, Qinghong, et al.
Publicado: (2022)

Time-Varying Effect of Hybrid Immunity on the Risk of Breakthrough Infection after Booster Dose of mRNA COVID-19 Vaccine: The MOSAICO Study
por: Ferrara, Pietro, et al.
Publicado: (2022)

Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases
por: Hasseli, Rebecca, et al.
Publicado: (2023)

Biotechnological Drugs: The Breakthrough in Autoimmune Rheumatic Conditions
por: Cavagna, Lorenzo, et al.
Publicado: (2014)

Correction to: DTaP‑IPV‑HepB‑Hib Vaccine (Hexyon(®)): An Updated Review of its Use in Primary and Booster Vaccination
por: Syed, Yahiya Y.
Publicado: (2019)

Correction: A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We Need
por: Moran, Mary
Publicado: (2005)

Correction to: Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study
por: Bodicoat, Danielle H., et al.
Publicado: (2020)

Correction to: Standardized nailfold capillaroscopy in children with rheumatic diseases: a worldwide study
Publicado: (2023)

Immune Responses and Breakthrough Infections After COVID-19 Vaccination
por: Kwon, Ki Tae
Publicado: (2023)

Future COVID-19 Booster Vaccine Refusal in Healthcare Workers after a Massive Breakthrough Infection Wave, a Nationwide Survey-Based Study
por: Gu, Fuying, et al.
Publicado: (2023)

Vaccine breakthrough infections with SARS-CoV-2: Why older adults need booster vaccinations
por: Ventura, Maria I., et al.
Publicado: (2022)

Correction: Socioeconomic and Environmental Risk Factors among Rheumatic Heart Disease Patients in Uganda
por: Okello, Emmy, et al.
Publicado: (2013)

Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab
por: Cross, Anne H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ptoe6dspud9slc1822rc6bj0dm